Nabilone

大麻隆

Report date: 2025/05/15 20:00:08
NME

Base Information

Drug NameNabilone
Drug Alias NameNabilonum大麻龙纳必龙nabilona纳比隆 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor agonists
TargetsCannabinoid receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticObsessive-Compulsive DisorderMarijuana Smoking +[19] 
Global Approved IndicationsVomitingNausea
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1985/12/26
Country/TerritoryCanadaUnited StatesMexico +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMeda Ab
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Manitoba
Inactive CompaniesInstituto Nacional De CancerologiaThe University Of Texas Health Science Center At HoustonMedical University Of Innsbruck +[9] 
Active IndicationsPruritusKidney Failure, Chronic
Inactive IndicationsStress Disorders, Post-TraumaticObsessive-Compulsive DisorderMarijuana Smoking +[17] 

Other Information

ATC CodeA04AD11
Related LinksWikipediaDrugBankKEGG